The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation

Conditions:   Systolic Heart Failure Stage D (Disorder);   Mitral Regurgitation Intervention:   Drug: evidence-based medications vs. high-dose hydralazine + evidence-based medications Sponsors:   Kaohsiung Veterans General Hospital.;   E-DA Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials